Innate Pharma SA banner

Innate Pharma SA
PAR:IPH

Watchlist Manager
Innate Pharma SA Logo
Innate Pharma SA
PAR:IPH
Watchlist
Price: 1.6 EUR -1.23%
Market Cap: €150.3m

DCF Value

The DCF Value for Innate Pharma SA (IPH) under the Base Case is 0.5 EUR. Compared with the current market price of 1.6 EUR, the stock appears Overvalued by 69% .

Key assumptions
IPH DCF Value
Base Case
0.5
Overvaluation 69%
DCF Value
Price €1.6
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett